FDA Guidance for Mobile Medical Applications

Summary

This document from the U.S. Food and Drug Administration provides guidance on how the agency regulates apps requiring clearance, such as Mobile Medical Applications (MMAs) and other mobile device software functions with a clinical application.

 

Details

Policy for Device Software Functions and Mobile Medical Applications

Document Preview
Download

View article on FDA's website.

 

Notes

  • None.

 

Resources

Print Article

Details

Article ID: 10741
Created
Wed 8/23/23 9:49 AM
Modified
Mon 3/18/24 1:35 PM
Author(s)
Dr. Cathy Goldstein, MD, MS

Related Articles (1)

This article provides general IRB guidance for investigators planning to include mobile apps, mobile devices, and other mobile technologies in human health research. It is not intended to address all aspects of an IRB review, only those related to mobile technologies.